D28-30787-01451
4 vaccinations
8 coded responses
52 check-ins
8 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 36-40
- ZIP prefix
- 015 / MA
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Registered in v-safe
-
2021-03-12
Dose 1 — Pfizer-BioNTech
- 2021-03-12
-
2021-03-13
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Muscle soreness around the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-14
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Slight muscle soreness around the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-26
-
2021-04-02
Dose 2 — Pfizer-BioNTech
-
2021-04-02
Survey response — day 0, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: Soreness/tenderness at the injection site, which I do not qualify as pain.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: Soreness at the injection site, which I dont qualify as pain.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Survey response — days 1–6 daily, dose 2MedDRA: Injection site discomfort — Feeling: GoodFree text: Soreness at injection site, which I do not qualify as painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Survey response — days 1–6 daily, dose 2MedDRA: Myalgia — Feeling: GoodFree text: Very mild muscle soreness at injection site, which I do not qualify as painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-07-02
- 2021-10-02
-
2021-11-29
Dose 3 — Pfizer-BioNTech
- 2021-11-29
-
2021-11-30
Survey response — days 1–6 daily, dose 3MedDRA: Injection site pain — Feeling: Good · Site: Pain, SwellingFree text: Muscle soreness on the upper arm where injection site is.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-01
- 2021-12-03
- 2021-12-04
- 2021-12-05
- 2021-12-08
- 2021-12-13
- 2021-12-20
- 2021-12-27
- 2022-01-03
- 2022-01-10
- 2022-02-28
- 2022-05-30
-
2022-09-19
Dose 4 — Pfizer-BioNTech
- 2022-09-19
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-24
- 2022-09-26
- 2022-10-03
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-10-31
-
2022-12-19
Survey response — 3 months, dose 4MedDRA: Dizziness, Nausea, Norovirus infection, Office visit, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Dizziness, nausea and vomiting, but not likely related to COVID; doctor suspected norovirus.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-19
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-12-20
Call successfulDoes not wish to fill out VAERS report
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Pfizer-BioNTech | |
| 2 | 2021-04-02 | Pfizer-BioNTech | |
| 3 | 2021-11-29 | Pfizer-BioNTech | No |
| 4 | 2022-09-19 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Muscle soreness around the injection site
Systemic reaction (other): Slight muscle soreness around the injection site
Release 6 — day 0, dose 2
Systemic reaction (other): Soreness/tenderness at the injection site, which I do not qualify as pain.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Soreness at the injection site, which I dont qualify as pain.
Systemic reaction (other): Soreness at injection site, which I do not qualify as pain
Systemic reaction (other): Very mild muscle soreness at injection site, which I do not qualify as pain
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Muscle soreness on the upper arm where injection site is.
Release 12 — 3 months, dose 4
Symptoms: Dizziness, nausea and vomiting, but not likely related to COVID; doctor suspected norovirus.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Norovirus infection | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Injection site discomfort | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release